• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单剂量头孢曲松预防肝硬化患者经颈静脉肝内门体分流术后的感染并发症

Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone.

作者信息

Gulberg V, Deibert P, Ochs A, Rossle M, Gerbes A L

机构信息

Department of Medicine II, Klinikum Grosshadem, University of Munich, Germany.

出版信息

Hepatogastroenterology. 1999 Mar-Apr;46(26):1126-30.

PMID:10370679
Abstract

BACKGROUND/AIMS: Patients with cirrhosis of the liver are prone to bacterial infections. Therapeutic interventions such as endoscopic sclerotherapy increase the risk of bacterial infections in these patients. Following insertion of a transjugular intrahepatic portosystemic shunt (TIPS), the incidence of severe bacterial infections was recently shown to be 20% after elective procedures. This finding suggests antibiotic prophylaxis with the TIPS procedure. Antibiotic prophylaxis using cefotiam or cefotaxime/ampicillin did not significantly reduce infectious complications. The aim of the present study was therefore to investigate the efficacy of two different doses of a long-acting cephalosporin in prevention of bacterial infection after TIPS.

METHODOLOGY

Eighty-two patients with cirrhosis (age: 52 +/- 2 years) who underwent elective TIPS were randomized to receive a single i.v. dose of either 1 g or 2 g Ceftriaxone 1 hour before the intervention. Patients with evidence of or suspected infections and patients on antibiotic therapy within 7 days prior to TIPS were excluded. Body temperature was monitored t.i.d. for 1 week and white blood count (WBC) and C-reactive protein (CRP) were determined before TIPS and 1 day and 1 week after TIPS.

RESULTS

Only 2 of 82 patients (2.6%) showed signs of infection following TIPS insertion: One of 40 patients receiving 1 g Ceftriaxone and 1 of 42 patients receiving 2 g Ceftriaxone prior to TIPS developed temperature > 38.5 degrees C. In the latter patient this was due to pneumonia. This patient received antibiotic treatment with imipenem for 10 days. Temperature in the other patient normalized within 12 hours and he did not require antibiotic treatment. No significant differences in temperature, WBC and CRP between the different doses of Ceftriaxone were observed.

CONCLUSIONS

Prophylactic treatment with Ceftriaxone reduces the reported incidence of bacterial infections after TIPS in patients with cirrhosis of the liver. Prophylaxis with 1 g Ceftriaxone seems as efficacious as 2 g.

摘要

背景/目的:肝硬化患者易发生细菌感染。诸如内镜硬化治疗等治疗干预措施会增加这些患者发生细菌感染的风险。最近研究显示,在进行经颈静脉肝内门体分流术(TIPS)后,择期手术患者中严重细菌感染的发生率为20%。这一发现提示在TIPS手术中应进行抗生素预防。使用头孢替安或头孢噻肟/氨苄西林进行抗生素预防并不能显著降低感染并发症的发生率。因此,本研究的目的是探讨两种不同剂量的长效头孢菌素在预防TIPS术后细菌感染中的疗效。

方法

82例接受择期TIPS的肝硬化患者(年龄:52±2岁)被随机分为两组,在干预前1小时分别静脉注射1 g或2 g头孢曲松。排除有感染证据或疑似感染的患者以及在TIPS术前7天内接受抗生素治疗的患者。术后连续3天每天监测体温1周,并在TIPS术前、术后1天和1周测定白细胞计数(WBC)和C反应蛋白(CRP)。

结果

82例患者中只有2例(2.6%)在TIPS术后出现感染迹象:40例术前接受1 g头孢曲松治疗的患者中有1例,42例术前接受2 g头孢曲松治疗的患者中有1例体温>38.5℃。后一例患者的发热是由肺炎引起的。该患者接受亚胺培南抗生素治疗10天。另一例患者的体温在12小时内恢复正常,无需抗生素治疗。不同剂量头孢曲松之间在体温、WBC和CRP方面未观察到显著差异。

结论

头孢曲松预防性治疗可降低肝硬化患者TIPS术后报告的细菌感染发生率。1 g头孢曲松预防似乎与2 g一样有效。

相似文献

1
Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone.单剂量头孢曲松预防肝硬化患者经颈静脉肝内门体分流术后的感染并发症
Hepatogastroenterology. 1999 Mar-Apr;46(26):1126-30.
2
Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.2型肝肾综合征与顽固性腹水:经颈静脉肝内门体分流术在18例等待原位肝移植的晚期肝硬化患者中的作用
Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5.
3
Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.接受大型肝外手术的经颈静脉肝内门体分流术肝硬化患者。
J Clin Gastroenterol. 2009 Jul;43(6):574-9. doi: 10.1097/MCG.0b013e31818738ef.
4
Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.经颈静脉肝内门体分流术(TIPS)对定量肝功能试验的影响。
Hepatogastroenterology. 1998 Nov-Dec;45(24):2315-21.
5
Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.诺氟沙星与头孢曲松预防晚期肝硬化合并出血患者感染的比较
Gastroenterology. 2006 Oct;131(4):1049-56; quiz 1285. doi: 10.1053/j.gastro.2006.07.010.
6
Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results.五例囊性纤维化患儿经颈静脉肝内门体分流术:长期结果
Hepatogastroenterology. 2003 Jul-Aug;50(52):1111-4.
7
Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial.内镜下静脉曲张套扎术联合普萘洛尔与经颈静脉肝内门体分流术:一项长期随机试验
Endoscopy. 2002 Sep;34(9):690-7. doi: 10.1055/s-2002-33565.
8
Surgical infections after laparoscopic cholecystectomy: ceftriaxone vs ceftazidime antibiotic prophylaxis. A prospective study.腹腔镜胆囊切除术后的手术感染:头孢曲松与头孢他啶抗生素预防。一项前瞻性研究。
Chir Ital. 2004 May-Jun;56(3):397-402.
9
Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.对细菌感染进行肠外抗生素预防并不能提高口服诺氟沙星对肝硬化合并胃肠道出血患者的成本效益。
Am J Gastroenterol. 1998 Dec;93(12):2457-62. doi: 10.1111/j.1572-0241.1998.00704.x.
10
Clotting activation after transjugular intrahepatic portosystemic stent shunt.
Thromb Haemost. 1999 May;81(5):711-4.

引用本文的文献

1
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice.肝硬化患者的抗生素预防:临床实践的当前证据
World J Hepatol. 2021 Aug 27;13(8):840-852. doi: 10.4254/wjh.v13.i8.840.
2
Bloodstream Infection and Its Clinical Characteristics and Relevant Factors Associated with Interventional Therapy in a Large Tertiary Hospital: A Six Years Surveillance Study.血流感染及其临床特征与大型三甲医院介入治疗相关因素的六年监测研究。
Biomed Res Int. 2019 Oct 21;2019:8190475. doi: 10.1155/2019/8190475. eCollection 2019.
3
Improved survival with the patients with variceal bleed.
静脉曲张出血患者的生存率提高。
Int J Hepatol. 2011;2011:356919. doi: 10.4061/2011/356919. Epub 2011 Jul 7.
4
Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.肝硬化合并上消化道出血患者的抗生素预防治疗
Cochrane Database Syst Rev. 2010 Sep 8;2010(9):CD002907. doi: 10.1002/14651858.CD002907.pub2.
5
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review.肺炎铜绿假单胞菌的亚胺培南耐药性:系统文献回顾。
BMC Pulm Med. 2010 Aug 26;10:45. doi: 10.1186/1471-2466-10-45.
6
Lack of portosystemic bacterial translocation in patients with liver cirrhosis after placement of transjugular shunt.经颈静脉分流术后肝硬化患者门体静脉细菌移位缺失。
Eur J Clin Microbiol Infect Dis. 2003 May;22(5):310-2. doi: 10.1007/s10096-003-0911-9. Epub 2003 May 7.